Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.

Nature·2026
Same author

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 American College of Cardiology Conference.

Current atherosclerosis reports·2026
Same author

Development of Clinical Practice Guidelines and Primary Care Referral Pathways for the Management of Otorhinolaryngological Conditions in Pakistan.

International archives of otorhinolaryngology·2026
Same author

NiAl-LDH nanocomposite: a promising platform for non-enzymatic electrochemical detection of nicotinic acid in food samples.

Food chemistry·2026
Same author

Role of Advanced MRI-Based Perfusion and Diffusion Imaging in Predicting Recovery After the Surgical Management of Cervical Myelopathy: A Retrospective Study.

Cureus·2026
Same author

Hypoalbuminemia as a predictor of mortality in patients with acute cholangitis: A systematic review and meta-analysis.

World journal of gastrointestinal pathophysiology·2026

Related Experiment Video

Updated: May 29, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Setting a Standard for Helicobacter pylori Management in Pakistan.

Syeda Amrah Hashmi1, Amna Rashid Hanfee2, Sajjan Raja2

  • 1Center for Clinical Best Practices, Clinical and Translational Research Incubator (CITRIC), Aga Khan University, Karachi, Pakistan.

The Korean Journal of Helicobacter and Upper Gastrointestinal Research
|May 28, 2026
PubMed
Summary

This study adapted clinical practice guidelines for Helicobacter pylori (H. pylori) management in Pakistan, recommending non-endoscopic testing for dyspepsia patients under 50 and endoscopic testing for those over 50.

Keywords:
GRADE approachH. pyloriPractice guidelines as topic

More Related Videos

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
06:40

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

Published on: July 28, 2023

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Related Experiment Videos

Last Updated: May 29, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
06:40

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

Published on: July 28, 2023

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Area of Science:

  • Gastroenterology
  • Evidence-based Medicine
  • Public Health

Background:

  • Helicobacter pylori (H. pylori) infection is highly prevalent in Pakistan, impacting approximately 81% of the population.
  • Developing new clinical practice guidelines (CPGs) is challenging for low- and middle-income countries (LMICs).
  • Adapting existing guidelines using the GRADE-ADOLOPMENT process offers a practical solution for LMICs.

Purpose of the Study:

  • To develop a contextually relevant and comprehensive CPG for H. pylori management in Pakistan.
  • To adapt existing high-quality CPGs to suit the specific needs and resources of Pakistan.
  • To provide Pakistani general physicians with effective H. pylori management strategies.

Main Methods:

  • Selected source guidelines were rigorously reviewed and evaluated using the GRADE approach.
  • Recommendations were classified as "Adopt," "Adapt," or "Exclude" by expert gastroenterologists.
  • The GRADE-ADOLOPMENT process, GRADEPro software, and Evidence to Decision tables facilitated consensus on the CPG.

Main Results:

  • Out of 33 recommendations from source guidelines, 29 were adopted, and 3 were excluded.
  • One recommendation was adapted: non-endoscopic testing for H. pylori is recommended for uninvestigated dyspepsia patients under 50 (previously under 60).
  • The adapted CPG recommends endoscopic testing for patients aged 50 and above with uninvestigated dyspepsia.

Conclusions:

  • The developed CPG provides Pakistani physicians with evidence-based strategies for H. pylori management.
  • The adapted guideline emphasizes age-specific testing protocols for H. pylori related to dyspepsia.
  • Further research is recommended to evaluate early screening for uninvestigated dyspepsia in Pakistan, with potential global applicability for LMICs.